TASHKENT, Uzbekistan, April 27. Uzbekistan and
China have discussed expanding cooperation in the pharmaceutical
sector, Trend reports
via Uzbekistan’s Agency for the Development of the Pharmaceutical
Industry.
The issue was reviewed during a meeting between Director of the
Agency for the Development of the Pharmaceutical Industry Abdulla
Azizov and representatives of China’s pharmaceutical industry.
During the talks, the sides explored opportunities to strengthen
cooperation in a range of areas, including pharmaceuticals
manufacturing, biotechnology, vaccines, blood products, active
pharmaceutical ingredients (APIs), generics, and innovative
medicines.
The Uzbek side also highlighted the country’s strong potential
to serve as a regional hub for the production and export of
pharmaceutical products. Officials pointed to Uzbekistan’s
strategic geographic location, access to Central Asian and CIS
markets, young and growing population, competitive production
costs, and investor incentives.
At the conclusion of the meeting, both sides expressed readiness
to deepen mutually beneficial cooperation and move forward with
practical joint projects in the pharmaceutical industry.
